The Impact of Diabetes on Early Outcomes after Routine Bilateral Internal Thoracic Artery Grafting

Giuseppe Gatti1, Luca Dell'Angela2, Luca Maschietto1

  • 1Division of Cardiac Surgery, Ospedali Riuniti and University of Trieste, Trieste, Italy.

Insights

Bilateral internal thoracic artery (BITA) grafting is safe for diabetic patients, showing no increase in early mortality despite higher complication rates. This cardiac surgery technique can be routinely performed in diabetic individuals.

Area of Science:

  • Cardiovascular Surgery
  • Diabetic Complications
  • Surgical Outcomes

Background:

  • Bilateral internal thoracic artery (BITA) grafting is limited in diabetic patients due to increased postoperative complication risks.
  • This study reviews routine BITA grafting to assess diabetes' impact on early outcomes.

Purpose of the Study:

  • To investigate the impact of diabetes on early outcomes following bilateral internal thoracic artery (BITA) grafting.
  • To compare postoperative complications and mortality between diabetic and non-diabetic patients undergoing BITA grafting.

Main Methods:

  • Retrospective review of 4508 coronary bypass surgery patients from 1999-2015.
  • Skeletonized BITA grafts used in 3228 patients (972 diabetic, 2256 non-diabetic).
  • Propensity score-matched analysis of 819 diabetic/non-diabetic pairs, comparing outcomes using EuroSCORE II for risk assessment.

Main Results:

  • Diabetic patients had higher baseline risk profiles (EuroSCORE II) in both unmatched and matched cohorts.
  • No significant difference in hospital mortality between diabetic and non-diabetic groups (2.1% vs. 2.3%, p=0.74 in matched pairs).
  • Diabetic patients experienced more frequent adrenergic agonist use, postoperative bleeding, and deep sternal wound infections, leading to longer hospital stays.

Conclusions:

  • Bilateral internal thoracic artery (BITA) grafting can be routinely performed in diabetic patients.
  • Despite higher complication rates and prolonged hospital stays, BITA grafting does not increase early mortality in diabetic patients.
Abstract